Venture · · 5 min read

Venture: Biotechnology

Issue 130;

Biotech is on the move once again, and one small niche in particular.

After the dotcom bust in 2000, the Nasdaq didn’t get going again until around 2010. Until that point, the two sectors ran neck and neck. The developments in life sciences have been enabled by the breakthroughs in computing in both power and speed, so it is little wonder they are connected. After all, before 2008, both sectors broadly lost money. It was biotech that changed that first, as ideas eventually turned into profits.

Nasdaq versus Nasdaq Biotech

Source: Bloomberg

Then in 2012, biotech raced ahead to be followed by a prolonged pause thereafter. There can be no doubt that developments in AI will boost biotech. The price action is starting to improve.

Venture is issued by ByteTree Asset Management Ltd, an appointed representative of Strata Global which is authorised and regulated by the Financial Conduct Authority. ByteTree Asset Management is a wholly owned subsidiary of ByteTree Group Ltd.

General - Your capital is at risk when you invest, never risk more than you can afford to lose. Past performance and forecasts are not reliable indicators of future results. Bid/offer spreads, commissions, fees and other charges can reduce returns from investments. There is no guarantee dividends will be paid. Overseas shares - Some recommendations may be denominated in a currency other than sterling. The return from these may increase or decrease as a result of currency fluctuations. Any dividends will be taxed at source in the country of issue.

Funds - Fund performance relies on the performance of the underlying investments, and there is counterparty default risk which could result in a loss not represented by the underlying investment. Exchange Traded Funds (ETFs) with derivative exposure (leveraged or inverted ETFs) are highly speculative and are not suitable for risk-averse investors.

Bonds - Investing in bonds carries interest rate risk. A bondholder has committed to receiving a fixed rate of return for a fixed period. If the market interest rate rises from the date of the bond's purchase, the bond's price will fall. There is also the risk that the bond issuer could default on their obligations to pay interest as scheduled, or to repay capital at the maturity of the bond.

Taxation - Profits from investments, and any profits from converting cryptocurrency back into fiat currency is subject to capital gains tax. Tax treatment depends on individual circumstances and may be subject to change.

Investment Director: Charlie Morris. Editors or contributors may have an interest in recommendations. Information and opinions expressed do not necessarily reflect the views of other editors/contributors of ByteTree Group Ltd. ByteTree Asset Management (FRN 933150) is an Appointed Representative of Strata Global Ltd (FRN 563834), which is regulated by the Financial Conduct Authority.

© 2026 ByteTree Group Ltd

Read next